CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease
about
A proposed classification of the immunological diseasesInteraction of Crohn's disease susceptibility genes in an Australian paediatric cohortInflammatory bowel diseaseDefects in mucosal immunity leading to Crohn's diseaseRecent Insights Into the Genetics of Inflammatory Bowel DiseaseThe molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn diseaseHorror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)The SPINK gene family and celiac disease susceptibilityAnti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutationsAssociation of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor 1 receptor with Crohn's disease: a case-control studyNovel biomarkers of fibrosis in Crohn's diseaseGenetic Influences on the Development of Fibrosis in Crohn's DiseaseMechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont SelectionHost-microbiome interaction in Crohn's disease: A familiar or familial issue?Role of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of AtherosclerosisRoles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseasesCorrelations between psoriasis and inflammatory bowel diseasesThe IL-23-IL-17 immune axis: from mechanisms to therapeutic testingGenetically determined epithelial dysfunction and its consequences for microflora-host interactionsInflammatory Bowel Disease Drugs: A Focus on AutophagyNod2: A Critical Regulator of Ileal Microbiota and Crohn's DiseaseInternational Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and diseaseNOD2: ethnic and geographic differencesCARD15/NOD2 mutations in Crohn's diseaseAssociations between NOD2/CARD15 genotype and phenotype in Crohn's disease--Are we there yet?Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel diseaseOrganic dust augments nucleotide-binding oligomerization domain expression via an NF-{kappa}B pathway to negatively regulate inflammatory responsesA new arthritis therapy with oxidative burst inducersModeling-Enabled Characterization of Novel NLRX1 LigandsRole of nod2 in the response of macrophages to toll-like receptor agonistsCritical role of NOD2 in regulating the immune response to Staphylococcus aureusInflammatory bowel diseaseInflammatory bowel diseaseGenetic variation in IBD: progress, clues to pathogenesis and possible clinical utilityNegligible impact of rare autoimmune-locus coding-region variants on missing heritabilityDense genotyping identifies and localizes multiple common and rare variant association signals in celiac diseaseGenotypes and phenotypes in Crohn's disease: do they help in clinical management?The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variantsCARD15/NOD2 is required for Peyer's patches homeostasis in mice.Positional cloning of Ncf1--a piece in the puzzle of arthritis genetics.
P2860
Q21144701-A4359C1F-CB9F-4C64-B2B2-A722EE73DC91Q21562133-2F4A5B1C-EFE3-456B-8D1B-3287CD159817Q22242222-191BB330-E658-4E02-AA0A-7CC16A29AE81Q22242645-9278A7CA-89C3-4ACB-A2AB-7567677DBE4FQ22250935-4935BD93-3047-4324-9338-F17DC32078B9Q24296753-414AA5EA-D57B-4CD8-B52E-7DDA817193A5Q24631660-F847E72E-2727-4783-89C0-9C3BC45530D0Q24676700-942D1E0D-AD4C-45DA-83D4-A3D392598709Q24684357-BE080985-9C9D-4AF7-AD47-0B5DB78F1768Q24794971-A529C2B0-500F-4CA8-8EDB-C29C9D1CFBBCQ26738287-D599BD58-D2DB-4443-BD0A-0E5849B4497DQ26745889-E69D75A5-DBBE-4009-968B-FE7611ED5153Q26774688-AE6DD836-3CBF-404A-B3C2-447091ABD2D3Q26776158-3667EB4B-26CD-4407-9A84-97D9E50FABDDQ26777991-CAFEEA32-14D7-4C58-AE40-FF9FF36F64C0Q26864035-48FC708C-98FB-4F2E-A4C8-B19D04E5F830Q27024863-137F201D-D5DE-4697-B04A-900292D4C357Q27687800-4F32D46A-DBB2-4B66-83A1-4304D2180341Q27690638-5A6F6DAB-F86B-4DBD-B965-4C23F7D10498Q28066443-92CE1EDA-F66F-4103-A446-41F11871D37CQ28079236-59265DF5-D84D-4D5F-91D8-0C50D69F4553Q28081406-7166FF85-3828-4793-9BAB-743AB545008BQ28246013-377F7591-D5B1-4CE6-8CF6-44A4879EE7DCQ28269971-590E21E8-6731-4F41-A71A-0794C880F230Q28276011-A35A8CD9-1661-4241-93C5-65FE212D4D82Q28300680-63033609-E1DB-4918-A1CB-75DA32B7FD9EQ28391980-2BD4CFB8-37F5-4262-B6AF-6D357004DB76Q28469045-A1128DD6-6B4C-4BF9-8AD5-8603A503C70DQ28551839-017BB964-4D28-4654-AEEB-1941954BA4E4Q28592332-3B660415-0DA6-4952-8697-C0EB5415FFBFQ28593011-0B700EBD-D0A1-4481-8A24-4DBE9B0130C1Q29615500-C3C40F58-9991-4483-876F-E27DF8657DA7Q29616286-7C934E70-5F9C-463C-B6D8-249A084142AEQ30251388-F7B77794-635A-4AFF-83F9-BE58BDD78C65Q30415780-526F319D-3D11-459A-9CD3-4B8058275D59Q30426720-1B4562E8-170C-4AFB-9053-8D3708627ED9Q30478821-E308CF44-EF18-4B3E-9914-0239DF67E7ABQ30994539-BE9BD791-463F-4966-9E03-37490322B723Q33287474-44C13FB6-A1FD-4698-AC1F-968C554FFE83Q33338551-4917F12B-D034-4B5A-AE8C-01C6B97F8339
P2860
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CARD15/NOD2 mutational analysi ...... ith inflammatory bowel disease
@en
CARD15/NOD2 mutational analysi ...... th inflammatory bowel disease.
@nl
type
label
CARD15/NOD2 mutational analysi ...... ith inflammatory bowel disease
@en
CARD15/NOD2 mutational analysi ...... th inflammatory bowel disease.
@nl
prefLabel
CARD15/NOD2 mutational analysi ...... ith inflammatory bowel disease
@en
CARD15/NOD2 mutational analysi ...... th inflammatory bowel disease.
@nl
P2093
P2860
P50
P921
P356
P1476
CARD15/NOD2 mutational analysi ...... ith inflammatory bowel disease
@en
P2093
Colm O'Morain
Corinne Gower-Rousseau
EPIMAD Group
EPWG-IBD Group
Françoise Merlin
GETAID Group
Gilles Thomas
Habib Zouali
Jacques Belaiche
P2860
P304
P356
10.1086/339432
P407
P577
2002-03-01T00:00:00Z